President and CEO
Abon Pharmaceuticals
Dr. Salah U. Ahmed is the Founder, President and CEO of Abon
Pharmaceuticals, LLC. Prior to the establishment of Abon in
2009, he was Executive Vice President of Global Research and
Development and Chief Scientific Officer at Barr Pharmaceuticals,
Inc. His leadership role in product development significantly
contributed to Barr’s transformation into a specialty
pharmaceutical company and a world leader in the generic
pharmaceuticals industry.
Dr. Ahmed has led diverse Research and Development operations in
the USA and several countries in Europe involving the development
of generic pharmaceuticals, proprietary pharmaceuticals, API and
biotechnology products. He managed a product portfolio with a broad
range of drug delivery systems including parenteral, nasal, ocular,
oral, transmucosal, transdermal and intrauterine routes of
administration.
He has a notable track record in pharmaceutical research
involving special drug delivery systems, solid-state interactions,
statistical design and mathematical modeling in product development
research, and in-vitro/in-vivo performance of dosage forms. He has
authored or co-authored more than 60 research papers,
abstracts and book chapters, and has been a distinguished speaker
at many pharmaceutical conferences and workshops in the USA and
Europe.
Dr. Ahmed received his MS in Industrial Pharmacy and Ph.D. in
Pharmaceutical Sciences from St. Johns University.